Methamphetamine abuse is a widespread problem for which there is currently no effective pharmacotherapy. This project will test the safety and efficacy of medications that modulate adrenergic function as treatments for methamphetamine dependence. In a coordinated series of inpatient laboratory and outpatient treatment studies, we will perform a systematic investigation of the utility of adrenergic compounds. The specific compounds that we propose examining are the alpha-2 agonist clonidine, the beta-blocker carvedilol, the alpha-l antagonist prazosin, and the norepinephrine reuptake inhibitor atomoxetine. As part of our research, we will develop new assay techniques and utilize population pharmacokinetic/pharmacodynamic modeling to provide a quantitative estimate of the amounts of illicit methamphetamine consumed during our trials. We postulate that quantifying the effects of candidate pharmacotherapies on illicit drug intake will substantially improve our ability to assess the effectiveness of our medications and therapeutic outcomes. Relapse to drug use occurs as a function of complex alterations in mood, craving, stress and withdrawal symptomatology. Surrogate markers can be essential in determining drug response. In our studies we will assess the utility of using the cytokines IL-6, C-reactive protein and tumor necrosis factor-alpha as surrogate makers of stress to predict relapse, measure drug effect, and determine outcome. Specific experiments are coordinated so that results from one experiment informs the design of subsequent, studies. In our laboratory component we will) assess interactions between our candidate drugs and methamphetamine, 2) develop and validate under controlled conditions our method to quantify illicit drug intake, and 3) evaluate methamphetamine-cytokine interactions. Results from these studies are used to advance two of the four adrenergic drugs from the inpatient laboratory to placebo-controlled outpatient treatment trials. In these outpatient trials we will 1) assess the clinical efficacy of these candidate drugs, 2) validate the quantitative methamphetamine ingestion method under real world conditions, and 3) determine the utility of our immune markers to predict relapse. Our focused, mechanistically-based studies present opportunities for methods development and efficacy evaluations that could not be practically achieved without a collaborative center.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA018179-05
Application #
7595108
Study Section
Special Emphasis Panel (ZDA1-KXA-N (22))
Program Officer
Oversby, Steven
Project Start
2004-09-29
Project End
2011-02-28
Budget Start
2009-03-01
Budget End
2011-02-28
Support Year
5
Fiscal Year
2009
Total Cost
$226,812
Indirect Cost
Name
California Pacific Medical Center Research Institute
Department
Type
DUNS #
071882724
City
San Francisco
State
CA
Country
United States
Zip Code
94107
Pal, Reshmi; Mendelson, John E; Flower, Keith et al. (2015) Impact of prospectively determined A118G polymorphism on treatment response to injectable naltrexone among methamphetamine-dependent patients: an open-label, pilot study. J Addict Med 9:130-5
Flower, Keith; Post, Anneke; Sussman, Jeremy et al. (2011) Validation of triage criteria for deciding which apparently inebriated persons require emergency department care. Emerg Med J 28:579-84
Galloway, G P; Buscemi, R; Coyle, J R et al. (2011) A randomized, placebo-controlled trial of sustained-release dextroamphetamine for treatment of methamphetamine addiction. Clin Pharmacol Ther 89:276-82
Galloway, Gantt P; Coyle, Jeremy R; Guillén, José Enrique et al. (2011) A simple, novel method for assessing medication adherence: capsule photographs taken with cellular telephones. J Addict Med 5:170-4
Flower, K; Li, L; Chen, C-Y A et al. (2010) Efficacy, safety, and ethics of cosmetic neurology far from settled. Clin Pharmacol Ther 88:461-3
Garrison, Kathleen J; Coyle, Jeremy R; Baggott, Matthew J et al. (2010) Imagery scripts and a computerized subtraction stress task both induce stress in methamphetamine users: a controlled laboratory study. Subst Abuse 4:53-60
Galloway, Gantt P; Singleton, Edward G; Buscemi, Raymond et al. (2010) An examination of drug craving over time in abstinent methamphetamine users. Am J Addict 19:510-4
Li, Linghui; Lopez, Juan Carlos; Galloway, Gantt P et al. (2010) Estimating the intake of abused methamphetamines using experimenter-administered deuterium labeled R-methamphetamine: selection of the R-methamphetamine dose. Ther Drug Monit 32:504-7
Li, Linghui; Everhart, Tom; Jacob Iii, Peyton et al. (2010) Stereoselectivity in the human metabolism of methamphetamine. Br J Clin Pharmacol 69:187-92
Baggott, Matthew J; Erowid, Earth; Erowid, Fire et al. (2010) Use patterns and self-reported effects of Salvia divinorum: an internet-based survey. Drug Alcohol Depend 111:250-6

Showing the most recent 10 out of 20 publications